There are 108 resources available
Invited Discussant 1619O and LBA67
Presenter: Javier Martin Broto
Session: Proffered Paper - Sarcoma
Resources:
Slides
Webcast
Invited Discussant LBA74 and LBA75
Presenter: Antonio Passaro
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Winette Van Der Graaf
Session: Proffered Paper - Sarcoma
Resources:
Webcast
Invited Discussant 524O, 525O and 526O
Presenter: Antoine Italiano
Session: Proffered Paper - Developmental therapeutics
Resources:
Slides
Webcast
Invited Discussant 527O and 528O
Presenter: Giulio Draetta
Session: Proffered Paper - Developmental therapeutics
Resources:
Slides
Webcast
528O - CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study
Presenter: Antoine Hollebecque
Session: Proffered Paper - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
1620O - Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma
Presenter: Joseph Ludwig
Session: Proffered Paper - Sarcoma
Resources:
Abstract
Slides
Webcast
LBA68 - Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with metastatic relapsed Ewing sarcoma (ES), on behalf of the French Sarcoma Group (FSG) and UNICANCER
Presenter: Florence Duffaud
Session: Proffered Paper - Sarcoma
Resources:
Abstract
Slides
Webcast
525O - A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies
Presenter: Geoffrey Ku
Session: Proffered Paper - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
LBA67 - TRAMUNE, a phase Ib study combining trabectedin and durvalumab, results of the expansion cohort in patients with advanced pretreated soft tissue sarcomas
Presenter: Maud Toulmonde
Session: Proffered Paper - Sarcoma
Resources:
Abstract
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.